GFACX
Price
$70.77
Change
+$0.82 (+1.17%)
Updated
Jul 31 closing price
Net Assets
356.86B
LGLFX
Price
$57.83
Change
+$0.49 (+0.85%)
Updated
Jul 31 closing price
Net Assets
7.43B
Interact to see
Advertisement

GFACX vs LGLFX

GFACX vs LGLFX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. LGLFX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and LGLFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 357B vs. LGLFX (7.43B). GFACX (0.00) and LGLFX (0.00) have matching dividends . GFACX was incepted earlier than LGLFX: GFACX (25 years) vs LGLFX (15 years). GFACX (1.35) is less costly to investors than LGLFX (0.74). LGLFX is a more actively managed with annual turnover of: 72.00 vs. GFACX (32.00). LGLFX has a lower initial minimum investment than GFACX: LGLFX (0) vs GFACX (250). LGLFX annual gain was more profitable for investors over the last year : 4.33 vs. GFACX (-0.98). LGLFX return over 5 years is better than : 16.31 vs. GFACX (3.92).
GFACXLGLFXGFACX / LGLFX
Total Expense Ratio1.350.64211%
Annual Report Gross Expense Ratio1.350.74182%
Fund Existence25 years15 years-
Gain YTD5.1562.845181%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets357B7.43B4,804%
Annual Yield % from dividends0.000.00-
Returns for 1 year-0.984.33-23%
Returns for 3 years27.7479.3235%
Returns for 5 years3.9216.3124%
Returns for 10 years76.09152.4250%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCGCX23.240.11
+0.48%
BlackRock Advantage Global Investor C
PGRNX23.820.09
+0.38%
Impax Global Environmental Markets Inv
SDVRX33.70-0.08
-0.24%
PGIM Quant Solutions Mid-Cap Val R
RYAKX79.47-0.62
-0.77%
Rydex Russell 2000 1.5x Strategy A
BHSRX58.34-0.65
-1.10%
BlackRock Health Sciences Opps R